Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.
This report contains market size and forecasts of Single Nucleotide Polymorphism (SNP) Genotyping in Global, including the following market information:
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Single Nucleotide Polymorphism (SNP) Genotyping market was valued at 17390 million in 2021 and is projected to reach US$ 63010 million by 2028, at a CAGR of 20.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transversion Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Single Nucleotide Polymorphism (SNP) Genotyping include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation and Enzo Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Single Nucleotide Polymorphism (SNP) Genotyping companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single Nucleotide Polymorphism (SNP) Genotyping Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, by Type, 2021 (%)
Transversion
Transition
Global Single Nucleotide Polymorphism (SNP) Genotyping Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, by Application, 2021 (%)
Diagnostics
Animal
Plant
Research
Others
Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Single Nucleotide Polymorphism (SNP) Genotyping revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Single Nucleotide Polymorphism (SNP) Genotyping revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences